March 18, 2016
AstraZeneca acquires all rights to Orexo´s OX-CLI project
Media
March 10, 2016
TARGOVAX ANNOUNCES ENCOURAGING INTERIM RESULTS WITH RAS SPECIFIC PEPTIDE VACCINE IN RESECTED PANCREATIC CANCER
March 09, 2016
Cancer Company Aprea Closes EUR 46 Million (~USD 51 Million) Series B Financing
March 07, 2016
Strongbridge Biopharma plc Provides Update on Corporate Progress
March 02, 2016
2015 annual results
March 02, 2016
INTERIM REPORT FOURTH QUARTER 2015
March 01, 2016
NANO: LATE-BREAKING ABSTRACT ON BETALUTIN® PHASE 1/2 STUDY ACCEPTED FOR PRESENTATION AT AMERICAN ASSOCIATION FOR CANCER RESEARCH ANNUAL MEETING 2016
March 01, 2016
BONESUPPORT™ ANNOUNCES AVAILABILITY IN EUROPE OF CERAMENT™|G IN 5 mL VOLUME TO ADDRESS GROWING MARKET DEMAND
March 01, 2016
Innovate Biopharmaceuticals Completes License For Late-Stage Celiac Disease Asset From Alba Therapeutics
February 29, 2016
GenSight Biologics Enrolls First Patient in Pivotal Phase III Program of GS010 in Leber’s Hereditary Optic Neuropathy